Cargando…
Innovative, enhanced community management of non-hypoxaemic chest-indrawing pneumonia in 2–59-month-old children: a cluster-randomised trial in Africa and Asia
INTRODUCTION: The WHO recommends oral amoxicillin for 2–59-month-old children with chest-indrawing pneumonia presenting at the health facility. Community-level health workers (CLHWs) are not allowed to treat these children when presented at the community level. This study aimed to evaluate whether C...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734014/ https://www.ncbi.nlm.nih.gov/pubmed/34987033 http://dx.doi.org/10.1136/bmjgh-2021-006405 |
Ejemplares similares
-
Editorial Commentary: Ambulatory Management of Chest-Indrawing Pneumonia
por: Qazi, Shamim A., et al.
Publicado: (2015) -
Malawian children with chest-indrawing pneumonia with and without comorbidities or danger signs
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Fast-breathing vs chest-indrawing childhood pneumonia: baseline characteristics
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021) -
Community case management of chest indrawing pneumonia in children aged 2 to 59 months by community health workers: study protocol for a multi-country cluster randomized open label non-inferiority trial
Publicado: (2020) -
Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian
children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)